Summary
Ben Greenfield visits Dr. Khanh Nguyen at Austin Regenerative Therapy for three days of advanced regenerative medicine treatments and reports on his firsthand experience. The episode covers cutting-edge protocols including young plasma exchange (using younger donor blood components), stem cell therapies, and other boundary-pushing regenerative approaches applied to the face and body. Dr. Nguyen draws on decades of internal medicine experience to explain the science behind these interventions and which patients benefit most.
The conversation explores how regenerative medicine is moving from fringe to frontier, with treatments that target biological aging at the cellular level. They discuss the practical realities of young plasma infusions, the different types of stem cell therapies available, and what the current evidence actually supports versus what remains speculative. Dr. Nguyen also shares her personal story as a Vietnamese refugee who became a leader in regenerative health, grounding the high-tech discussion in a deeply human narrative.
Key Points
- Young plasma exchange involves using blood components from younger donors to potentially rejuvenate aging tissue, though evidence is still emerging
- Stem cell therapies are being applied for full-body regeneration, facial rejuvenation, and tissue repair with varying levels of clinical evidence
- Regenerative medicine protocols often combine multiple therapies (plasma, stem cells, growth factors) for synergistic effects
- Not all regenerative treatments are equally supported by research; it is important to distinguish proven protocols from experimental ones
- Dr. Nguyen combines internal medicine expertise with regenerative techniques for a more comprehensive patient assessment
- These treatments are currently expensive and available primarily at specialized clinics, not yet mainstream
- Ben underwent three full days of treatments, suggesting these are intensive protocols rather than one-off procedures
Key Moments
Young plasma exchange: replacing old plasma with donor plasma from 18-25 year olds
Therapeutic plasma exchange swaps old plasma for albumin. Young plasma exchange replaces it with plasma from donors aged 18-25.
"Young plasma exchange is removing the old plasma, but the step beyond that is replacing with actual human plasma from young donors aged 18 to 25."
